[uam_ad id="317182"]

RIO DE JANEIRO, BRAZIL - The Senate confirmed yesterday the decision to release almost R$2 billion (US$400 million) to enable the purchase and final processing by Fiocruz (Oswaldo Cruz Foundation) of the vaccine against Covid-19 under development by Oxford University and marketed . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?